These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34793885)

  • 41. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.
    Shao D; Liu X; Wu J; Zhang A; Bai Y; Zhao P; Li J
    Phytomedicine; 2022 Jul; 102():154177. PubMed ID: 35636171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
    Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
    Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resveratrol mediated the proliferation and apoptosis of gastric cancer cells by modulating the PI3K/Akt/P53 signaling pathway.
    Dong Q; Zheng A; Zhai H; Zhang T
    Biochem Biophys Res Commun; 2024 Sep; 723():150186. PubMed ID: 38830298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
    Tang N; Zhang Q; Fang S; Han X; Wang Z
    Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway.
    Li H; Chen M; Yang Z; Xu C; Yu Q; Song J; Wang M; Gao X
    J Ethnopharmacol; 2022 Mar; 286():114926. PubMed ID: 34929308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkaloids of Aconiti Lateralis Radix Praeparata inhibit growth of non-small cell lung cancer by regulating PI3K/Akt-mTOR signaling and glycolysis.
    Zhang W; Cai S; Qin L; Feng Y; Ding M; Luo Z; Shan J; Di L
    Commun Biol; 2024 Sep; 7(1):1118. PubMed ID: 39261597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.
    Yuan C; Wang MH; Wang F; Chen PY; Ke XG; Yu B; Yang YF; You PT; Wu HZ
    Life Sci; 2021 Apr; 270():119105. PubMed ID: 33497736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway.
    Li B; Yuan Z; Jiang J; Rao Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30420490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San.
    Zhang S; Lu Y; Chen W; Shi W; Zhao Q; Zhao J; Li L
    Drug Des Devel Ther; 2021; 15():3425-3441. PubMed ID: 34385814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study on the Mechanism of Prunella Vulgaris L on Diabetes Mellitus Complicated with Hypertension Based on Network Pharmacology and Molecular Docking Analyses.
    Jiao X; Liu H; Lu Q; Wang Y; Zhao Y; Liu X; Liu F; Zuo Y; Wang W; Li Y
    J Diabetes Res; 2021; 2021():9949302. PubMed ID: 34692849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.
    Li H; Wang S; Takayama K; Harada T; Okamoto I; Iwama E; Fujii A; Ota K; Hidaka N; Kawano Y; Nakanishi Y
    Lung Cancer; 2015 Apr; 88(1):1-8. PubMed ID: 25670150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delicaflavone induces apoptosis via mitochondrial pathway accompanying G2/M cycle arrest and inhibition of MAPK signaling cascades in cervical cancer HeLa cells.
    Yao W; Lin Z; Wang G; Li S; Chen B; Sui Y; Huang J; Liu Q; Shi P; Lin X; Liu Q; Yao H
    Phytomedicine; 2019 Sep; 62():152973. PubMed ID: 31177019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seladoeflavones A-F, six novel flavonoids from Selaginella doederleinii.
    Zou Z; Xu K; Xu P; Li X; Cheng F; Li J; Yu X; Cao D; Li D; Zeng W; Zhang G; Tan G
    Fitoterapia; 2017 Jan; 116():66-71. PubMed ID: 27889540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.
    Hao P; Huang Y; Peng J; Yu J; Guo X; Bao F; Dian Z; An S; Xu TR
    Exp Cell Res; 2021 Jun; 403(2):112615. PubMed ID: 33894221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway.
    Zheng R; Jiang H; Li J; Liu X; Xu H
    Curr Cancer Drug Targets; 2017; 17(4):376-385. PubMed ID: 28093061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticancer effect of covalent purine-containing EGFR TKI, ZZC4 and its mechanism of action through network pharmacology.
    Attiogbe MKI; Zhao HY; Wang J; Huang TT; Yan PP; Liu YN; Li W; Cao L; Zhang SQ; Cao YX
    Life Sci; 2024 Jan; 336():122308. PubMed ID: 38030059
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DP from Euphorbia fischeriana S. mediated apoptosis in leukemia cells via the PI3k/Akt signaling pathways.
    Ma L; Chen Z; Li J; Zhang H; Jia Y; Liu J
    J Ethnopharmacol; 2021 Oct; 279():113889. PubMed ID: 33524514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT.
    Zhao YY; Jia J; Zhang JJ; Xun YP; Xie SJ; Liang JF; Guo HG; Zhu JZ; Ma SL; Zhang SR
    Acta Pharmacol Sin; 2021 Aug; 42(8):1288-1297. PubMed ID: 33159174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway.
    Fan Q; Lu Q; Wang G; Zhu W; Teng L; Chen W; Bi L
    J Ethnopharmacol; 2022 Dec; 299():115546. PubMed ID: 35850313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.